NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Chenling Capital

Chenling Capital

Hong Kongcdginv.com

Overview

Chenling Capital (also known as CDG Capital) is a private equity firm founded in 2016 that focuses on innovative value-investing and value-creation, targeting healthcare, high-end manufacturing, and new energy sectors.

Year Founded

2016

Portfolio Companies

1

Website

cdginv.com

Investments

Chenling Capital investments
CompanyDateStageLead
Jiangsu Synthgene Biotechnology Co., Ltd.Nov 2021Series BCo-investor
Jiangsu Synthgene Biotechnology Co., Ltd.Nov 2020Series A ExtensionCo-investor

Key People

Steven Li

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHong Kong
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.